Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02935361
Recruitment Status : Active, not recruiting
First Posted : October 17, 2016
Last Update Posted : April 6, 2021
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Van Andel Research Institute
Information provided by (Responsible Party):
University of Southern California

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 30, 2022
Estimated Study Completion Date : November 30, 2023